We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUD
2101
DELISTED
Audacy, Inc.
AUD
$50.6M ﹤0.01%
10,897,720
-222,365
-2% -$929K
MDLA
2102
DELISTED
Medallia, Inc.
MDLA
$50.4M ﹤0.01%
1,620,908
+115,956
+8% +$3.43M
TISI icon
2103
Team
TISI
$77.7M
$50.3M ﹤0.01%
315,272
+7,691
+3% +$1.3M
FOR icon
2104
Forestar Group
FOR
$1.51B
$50.2M ﹤0.01%
2,408,614
+76,098
+3% +$1.49M
EBSB
2105
DELISTED
Meridian Bancorp, Inc.
EBSB
$50.2M ﹤0.01%
2,499,671
-37,639
-1% -$738K
BTI icon
2106
British American Tobacco
BTI
$128B
$50M ﹤0.01%
1,177,146
-127,560
-10% -$4.81M
NCMI icon
2107
National CineMedia
NCMI
$378M
$50M ﹤0.01%
685,611
+6,305
+0.9% +$475K
ELF icon
2108
e.l.f. Beauty
ELF
$5.8B
$49.7M ﹤0.01%
3,082,137
+265,367
+9% +$4.42M
ACLS icon
2109
Axcelis
ACLS
$4.31B
$49.7M ﹤0.01%
2,062,027
+76,483
+4% +$1.61M
SPPI
2110
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$49.3M ﹤0.01%
13,556,091
+767,600
+6% +$6.2M
CASS icon
2111
Cass Information Systems
CASS
$743M
$49.3M ﹤0.01%
854,381
+15,578
+2% +$872K
ACB
2112
Aurora Cannabis
ACB
$185M
$49.3M ﹤0.01%
190,085
+2,051
+1% +$765K
LMAT icon
2113
LeMaitre Vascular
LMAT
$1.86B
$49.2M ﹤0.01%
1,368,353
+7,831
+0.6% +$270K
AMRX icon
2114
Amneal Pharmaceuticals
AMRX
$5.79B
$49.1M ﹤0.01%
10,185,075
+715,341
+8% +$2.49M
LEN.B icon
2115
Lennar Class B
LEN.B
$20.8B
$49M ﹤0.01%
1,154,173
+43,794
+4% +$1.95M
TTGT icon
2116
TechTarget
TTGT
$278M
$49M ﹤0.01%
1,876,917
+65,490
+4% +$1.66M
LQD icon
2117
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$48.9M ﹤0.01%
382,500
PAGP icon
2118
Plains GP Holdings
PAGP
$4.9B
$48.6M ﹤0.01%
2,565,584
-52,955
-2% -$993K
DO
2119
DELISTED
Diamond Offshore Drilling
DO
$48.6M ﹤0.01%
6,758,232
+665,138
+11% +$3.86M
CDNA icon
2120
CareDx
CDNA
$2.42B
$48.5M ﹤0.01%
2,248,485
-70,599
-3% -$1.62M
CYTK icon
2121
Cytokinetics
CYTK
$10.4B
$48.2M ﹤0.01%
4,545,990
+234,549
+5% +$2.41M
TPC
2122
Tutor Perini Cor
TPC
$5.21B
$48.2M ﹤0.01%
3,744,345
+296,599
+9% +$4.57M
IAG icon
2123
IAMGOLD
IAG
$10.6B
$48.1M ﹤0.01%
12,899,865
+118,292
+0.9% +$418K
ZLAB icon
2124
Zai Lab
ZLAB
$2.62B
$48.1M ﹤0.01%
1,156,175
+5,308
+0.5% +$196K
FORR icon
2125
Forrester Research
FORR
$228M
$48.1M ﹤0.01%
1,152,421
+27,885
+2% +$1.04M

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.